Literature DB >> 24453777

Natural history of multiple sclerosis symptoms.

Ilya Kister1, Tamar E Bacon1, Eric Chamot1, Amber R Salter1, Gary R Cutter1, Jennifer T Kalina1, Joseph Herbert1.   

Abstract

The North American Research Committee on Multiple Sclerosis (NARCOMS) Registry is a database that contains information from over 35,000 patient volunteers on symptom severity in 11 domains commonly affected in multiple sclerosis (MS): mobility, hand function, vision, fatigue, cognition, bowel/bladder function, sensory, spasticity, pain, depression, and tremor/coordination. The Registry affords a unique opportunity to study the frequency and severity of domain-specific impairment in a contemporary, mostly treated MS cohort over the course of the disease. The objective of this work was to calculate symptom prevalence in each of the 11 domains for years 0 to 30 from symptom onset. The resulting "symptom prevalence tables" demonstrate that a majority of participants perceive at least some degree of impairment in most domains as early as the first year of disease. The severity of impairment increases with disease duration across all domains, but the patterns of disability accumulation differ. The symptom prevalence tables illustrate the magnitude of perceived impact of the disease and highlight the extent of unmet need in symptomatic management. The tables are easy to use and allow MS patients and their clinicians to compare an individual's own impairment in any of the 11 domains to that of NARCOMS participants with the same disease duration.

Entities:  

Year:  2013        PMID: 24453777      PMCID: PMC3883021          DOI: 10.7224/1537-2073.2012-053

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  24 in total

1.  Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium.

Authors:  Ilya Kister; Eric Chamot; Joshua H Bacon; Gary Cutter; Joseph Herbert
Journal:  Mult Scler       Date:  2011-01-26       Impact factor: 6.312

2.  Urinary, faecal and sexual dysfunction in patients with multiple sclerosis.

Authors:  A Hennessey; N P Robertson; R Swingler; D A Compston
Journal:  J Neurol       Date:  1999-11       Impact factor: 4.849

3.  MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability.

Authors:  D K B Li; U Held; J Petkau; M Daumer; F Barkhof; F Fazekas; J A Frank; L Kappos; D H Miller; J H Simon; J S Wolinsky; M Filippi
Journal:  Neurology       Date:  2006-05-09       Impact factor: 9.910

4.  Longitudinal follow-up of "benign" multiple sclerosis at 20 years.

Authors:  Ana-Luiza Sayao; Virginia Devonshire; Helen Tremlett
Journal:  Neurology       Date:  2007-02-13       Impact factor: 9.910

5.  Disability in multiple sclerosis: a reference for patients and clinicians.

Authors:  Ilya Kister; Eric Chamot; Amber R Salter; Gary R Cutter; Tamar E Bacon; Joseph Herbert
Journal:  Neurology       Date:  2013-02-20       Impact factor: 9.910

6.  Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group.

Authors:  C E Schwartz; T Vollmer; H Lee
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

7.  Mood disorder and multiple sclerosis.

Authors:  R T Joffe; G P Lippert; T A Gray; G Sawa; Z Horvath
Journal:  Arch Neurol       Date:  1987-04

8.  Validity of performance scales for disability assessment in multiple sclerosis.

Authors:  R A Marrie; M Goldman
Journal:  Mult Scler       Date:  2007-07-10       Impact factor: 6.312

9.  Depression and multiple sclerosis.

Authors:  A D Sadovnick; R A Remick; J Allen; E Swartz; I M Yee; K Eisen; R Farquhar; S A Hashimoto; J Hooge; L F Kastrukoff; W Morrison; J Nelson; J Oger; D W Paty
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

10.  Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study.

Authors:  Sean J Pittock; Robyn L McClelland; William T Mayr; Neal W Jorgensen; Brian G Weinshenker; John Noseworthy; Moses Rodriguez
Journal:  Ann Neurol       Date:  2004-08       Impact factor: 10.422

View more
  82 in total

Review 1.  Response Heterogeneity With Exercise Training and Physical Activity Interventions Among Persons With Multiple Sclerosis.

Authors:  Jessica F Baird; Robert W Motl
Journal:  Neurorehabil Neural Repair       Date:  2018-12-26       Impact factor: 3.919

Review 2.  Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.

Authors:  Uwe K Zettl; Paulus Rommer; Petra Hipp; Robert Patejdl
Journal:  Ther Adv Neurol Disord       Date:  2016-01       Impact factor: 6.570

Review 3.  Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future.

Authors:  Itay Raphael; Johanna Webb; Olaf Stuve; William Haskins; Thomas Forsthuber
Journal:  Expert Rev Clin Immunol       Date:  2014-12-18       Impact factor: 4.473

Review 4.  Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives.

Authors:  Ulrik Dalgas; Martin Langeskov-Christensen; Egon Stenager; Morten Riemenschneider; Lars G Hvid
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

5.  Efficacy of inpatient personalized multidisciplinary rehabilitation in multiple sclerosis: behavioural and functional imaging results.

Authors:  Priska Zuber; Charidimos Tsagkas; Athina Papadopoulou; Laura Gaetano; Manuel Huerbin; Emanuel Geiter; Anna Altermatt; Katrin Parmar; Thierry Ettlin; Corina Schuster-Amft; Zorica Suica; Hala Alrasheed; Jens Wuerfel; Jürg Kesselring; Ludwig Kappos; Till Sprenger; Stefano Magon
Journal:  J Neurol       Date:  2020-03-02       Impact factor: 4.849

6.  The development of a short form of the DePaul Symptom Questionnaire.

Authors:  Madison Sunnquist; Savitri Lazarus; Leonard A Jason
Journal:  Rehabil Psychol       Date:  2019-07-18

7.  The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.

Authors:  Helen Tedeholm; Bengt Skoog; Vera Lisovskaja; Björn Runmarker; Olle Nerman; Oluf Andersen
Journal:  J Neurol       Date:  2015-02-26       Impact factor: 4.849

8.  Disability in multiple sclerosis: a reference for patients and clinicians.

Authors:  Ilya Kister; Eric Chamot; Amber R Salter; Gary R Cutter; Tamar E Bacon; Joseph Herbert
Journal:  Neurology       Date:  2013-02-20       Impact factor: 9.910

9.  Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation Study.

Authors:  Pei-Jung Lin; Cayla J Saret; Peter J Neumann; Eileen A Sandberg; Joshua T Cohen
Journal:  Pharmacoeconomics       Date:  2016-12       Impact factor: 4.981

10.  Orofacial evaluation in patients with multiple sclerosis using Nordic Orofacial Test-Screening.

Authors:  Marcela Leticia Leal Gonçalves; Cristiane Miranda França; Yara Dadalti Fragoso; Alessandro Melo Deana; Larissa Mateus de Almeida; Sandra Kalil Bussadori
Journal:  Clin Oral Investig       Date:  2016-09-06       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.